C07K 16/2884
Against cd44
Official title: {against CD44}
C07K16/2884 (Against cd44) appears on 80 US grants and 157 published applications in this corpus.
Search patents in C07K- Granted patents
- 80
- Published applications
- 157
- Assignees
- 112
- Inventors
- 339
- Latest grant
- 27 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 7 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 3 |
| 2003 | 0 | 4 |
| 2004 | 0 | 3 |
| 2005 | 1 | 7 |
| 2006 | 0 | 2 |
| 2007 | 2 | 8 |
| 2008 | 1 | 7 |
| 2009 | 2 | 7 |
| 2010 | 2 | 5 |
| 2011 | 6 | 8 |
| 2012 | 5 | 5 |
| 2013 | 5 | 6 |
| 2014 | 0 | 3 |
| 2015 | 5 | 13 |
| 2016 | 4 | 8 |
| 2017 | 2 | 5 |
| 2018 | 1 | 5 |
| 2019 | 4 | 8 |
| 2020 | 4 | 2 |
| 2021 | 3 | 11 |
| 2022 | 3 | 9 |
| 2023 | 3 | 10 |
| 2024 | 2 | 8 |
| 2025 | 4 | 8 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antibodies specific to CD4427 May 2025US 12,311,031 B2Multitude Inc.
- CAR NK cells20 May 2025US 12,304,962 B2Glycostem Therapeutics B.V.
- Paramagnetic immunobeads for the isolation of human adipose-derived stem cells8 Apr 2025US 12,270,808 B2University of Florida Research Foundation, Inc.
- Fusion constructs and methods of using thereof14 Jan 2025US 12,194,094 B2Precigen, Inc.
- Sensor for liquid biopsy and its method of making, and method of non-invasive liquid biopsy17 Sep 2024US 12,092,636 B2City University of Hong Kong
- Antibody-drug conjugate, preparation method and use thereof18 Jun 2026US 2026/0166169 A1Multitude Therapeutics Inc.
- Liposomal nanocarrier delivery system for targeting active cd44 molecule, preparation method therefor, and uses thereof12 Mar 2026US 2026/0069710 A1Beijing Inno Medicine Co., Ltd.
- Binding protein6 Nov 2025US 2025/0340662 A1Akiram Therapeutics AB
- Fusion constructs and methods of using thereof23 Oct 2025US 2025/0325665 A1Precigen, Inc.
- Anti-glyco-cd44 antibodies and their uses23 Oct 2025US 2025/0326855 A1GO Therapeutics, Inc.
Most cited
By later US patents
- Method of control leukocyte extravasation71US 5,538,724 AThe Board of Trustees for the Leland Stanford Junior Univ. · 1996
- T-cell redirecting bispecific antibodies for treatment of disease39US 9,315,567 B2IBC Pharmaceuticals, Inc. · 2016
- DNA sequence encoding a lymphocyte adhesion receptor for high endothelium35US 5,002,873 AFred Hutchinson Cancer Research Center · 1991
- Process for preparing purified drug conjugates32US 8,383,122 B2ImmunoGen, Inc. · 2013
- Process for preparing purified drug conjugates28US 7,811,572 B2ImmunoGen, Inc. · 2010